Furthermore, GLP-1 receptor (GLP-1R) agonists are widely used for treating Type 2 diabetes due to their ability to enhance glucose-dependent insulin secretion, reduce glucagon levels, and minimize the risk of hypoglycemia (Drucker, 2018). The gene discussed is INS; the disease is Hypoglycemia.